Getinge

Getinge
source
Name	Getinge
Type	Publicly traded company
Industry	Medical technology
Founded	1904
Headquarters	Getinge, Sweden
Key people	Johan Malmquist, Johan Malmquist
Products	Surgical tables, ventilators, sterilization systems, patient monitoring
Revenue	SEK (varies by year)
Employees	~10,000 (approx.)
Website	official website

Getinge Getinge is a Swedish medical technology company headquartered in Getinge, Västra Götaland County, Sweden. The company develops medical devices and healthcare solutions for acute care, surgical workflows, and life science applications, serving hospitals, research institutions, and pharmaceutical companies across Europe, North America, Asia, and other regions. Its operations intersect with major multinational firms and institutions including Johnson & Johnson, Medtronic, Abbott Laboratories, Pfizer, and regulatory agencies such as the European Medicines Agency and the U.S. Food and Drug Administration.

History

Getinge’s origins date to 1904 in the town bearing its name, where early industrial activity paralleled developments in Sweden’s manufacturing sector and the broader Industrial Revolution in Scandinavia. Throughout the 20th century the company expanded from local engineering into medical technology, mirroring trajectories of peers such as GE Healthcare, Siemens Healthineers, and Philips. During the late 20th and early 21st centuries, strategic acquisitions and internationalization aligned Getinge with global groups like Fresenius Medical Care and Baxter International. Corporate milestones intersected with major global events, including increased demand during the COVID-19 pandemic and regulatory scrutiny comparable to cases involving Boston Scientific and Stryker Corporation.

Products and Services

Getinge offers a portfolio spanning acute care and life sciences. Core offerings include surgical equipment such as operating-room tables comparable to those supplied by Hill-Rom, anesthesia systems analogous to products from Drägerwerk, and ventilators used in intensive care alongside devices from Philips Respironics. Infection control solutions feature sterilization units and washers that operate in contexts shared with Ecolab and STERIS Corporation. For life sciences, the company supplies bioprocess systems used by firms like Merck Group (MilliporeSigma) and Thermo Fisher Scientific, supporting vaccine and biologics production for companies such as Moderna and AstraZeneca. Getinge’s service offerings include maintenance, software for surgical workflow similar to platforms from Cerner Corporation and Epic Systems Corporation, and training services comparable to programs run by Red Cross-affiliated institutions.

Corporate Structure and Ownership

Getinge is publicly listed on the Nasdaq Stockholm exchange and is governed by a board of directors and executive management in line with Swedish corporate governance codes influenced by frameworks like the Swedish Corporate Governance Board. Major institutional shareholders include Scandinavian and international asset managers akin to Nordea, Handelsbanken, and BlackRock. The group is organized into business segments paralleling industry peers: surgical care, acute care, and life sciences, coordinating with regional subsidiaries across United States, China, Germany, and United Kingdom. Strategic alliances and joint ventures have been formed with companies such as GE Healthcare and research organizations including Karolinska Institutet.

Financial Performance

Getinge’s financial profile has shown revenue streams from product sales, services, and recurring consumables, comparable to patterns seen at Stryker Corporation and Zimmer Biomet. Annual reports and quarterly statements—prepared under International Financial Reporting Standards—detail fluctuations in net sales, operating margin, and order intake influenced by global demand cycles, currency exposure tied to Swedish krona, and capital investments. Major financial events have included significant restructuring charges and impairment assessments similar to those experienced by Siemens divisions, and the company’s performance is tracked by equity analysts covering the Nordic markets and global healthcare sector.

Research, Innovation, and Acquisitions

Getinge invests in research and development to advance areas such as infection prevention, surgical ergonomics, and bioprocessing technologies, engaging with academic partners like Lund University and research centers comparable to Fraunhofer Society. Its acquisition strategy mirrors that of industry consolidators such as Becton Dickinson and 3M Healthcare, acquiring niche firms to expand capabilities in disposables, software, and sterilization. Collaborative projects with pharmaceutical firms like Roche and Johnson & Johnson have supported development of sterile manufacturing solutions and validation protocols used in biologics production.

Environmental, Social, and Governance (ESG)

Getinge publicly reports on sustainability metrics aligned with frameworks such as the Task Force on Climate-related Financial Disclosures and works to reduce emissions consistent with Paris Agreement objectives. Environmental initiatives include energy efficiency in manufacturing sites and waste management programs comparable to those at Novo Nordisk and IKEA-owned facilities. Social commitments encompass workforce safety, diversity policies paralleling guidelines from International Labour Organization, and community engagement through partnerships with healthcare NGOs such as Médecins Sans Frontières. Governance practices follow Swedish rules with oversight by auditors and shareholders in a manner similar to other Nordic corporates.

Controversies and Legal Issues

Getinge has faced legal and regulatory challenges involving product performance, recall actions, and litigation, reflecting industry-wide risks akin to controversies encountered by Abbott Laboratories and Philips. Notable disputes have included claims related to sterilization equipment reliability and class-action style suits alleging impacts on patient outcomes, drawing attention from authorities like the U.S. Department of Justice and national healthcare regulators. These matters have prompted corporate remediation, settlements, and changes to quality systems in line with corrective actions pursued by other medical device firms.

Category:Medical technology companies Category:Companies of Sweden